The global biomarkers market was valued at US$ 51.2 Billion in 2022 and is projected to expand at a robust CAGR of 10.4% from 2023 to 2031, reaching more than US$ 125.6 Billion by the end of 2031. This strong growth trajectory is driven by the rising prevalence of chronic diseases, increasing adoption of personalized medicine, rapid technological advancements in diagnostics, and expanding applications of biomarkers across healthcare and life sciences.
Access key findings and insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=520
Key Market Growth Drivers
Rise in Prevalence of Chronic Diseases
The increasing incidence of chronic diseases worldwide is a major driver fueling biomarkers market growth. Biomarkers serve as critical tools for early disease detection, diagnosis, prognosis, and treatment monitoring in conditions such as cancer, cardiovascular diseases, diabetes, and neurological disorders.
According to the World Health Organization, non-communicable diseases account for 74% of global deaths, with cardiovascular diseases and cancer being the leading causes. In the United States, nearly 60% of individuals live with at least one chronic condition, while in India, approximately 21% of older adults suffer from at least one chronic disease, with hypertension and diabetes being the most prevalent. Biomarkers play a vital role in addressing this growing healthcare burden by enabling timely and personalized medical interventions.
Increase in Significance of Companion Diagnostics
Companion diagnostics have become an essential component of modern personalized medicine, significantly boosting demand for biomarkers. These diagnostic tools help identify patients who are most likely to benefit from specific therapies by analyzing genetic mutations, protein levels, or molecular markers.
In complex diseases such as cancer, companion diagnostics improve treatment efficacy, minimize adverse effects, and enhance clinical outcomes. By enabling patient stratification and therapy optimization, biomarkers used in companion diagnostics are emerging as a major catalyst for market expansion.
Market Challenges & Opportunities
Despite strong growth prospects, the biomarkers market faces challenges such as high costs associated with advanced diagnostic technologies, complexities in biomarker validation, and regulatory hurdles related to clinical approval.
However, these challenges also create opportunities for innovation. Increasing investments in R&D, growing demand for early disease detection, and expanding use of biomarkers in preventive healthcare are opening new avenues for market players. Advances in molecular diagnostics and data analytics are further expected to enhance biomarker discovery and commercialization.
Market Segmentations
• Product & Service
o Consumables
o Services
o Equipment
• Type
o Safety Biomarkers
o Susceptibility/Risk Biomarkers
o Diagnostic Biomarkers
o Prognostic Biomarkers
o Monitoring Biomarkers
o Predictive Biomarkers
o Pharmacodynamic/Response Biomarkers
• Application
o Diagnostics
o Drug Discovery & Development
o Personalized Medicine
o Disease Risk Assessment
o Others
• Disease Indication
o Cancer
o Neurological Disorders
o Cardiovascular Disorders
o Infectious Diseases
o Immune Disorders
o Others
Explore our report to uncover in-depth insights - https://www.transparencymarketresearch.com/biomarkers-market.html
Regional Outlook: Biomarkers Market
North America is the leading and most profitable region in the global biomarkers market. The region benefits from a high disease burden, strong adoption of biomarkers across diagnostics and drug development, substantial research funding, and frequent product launches.
Europe is experiencing steady growth due to increased focus on personalized medicine, favorable regulatory environments, and rising investments in healthcare research and development.
Asia Pacific is emerging as a high-growth region, driven by the rising incidence of cancer and other chronic diseases, increasing adoption of molecular diagnostics, and expanding access to biomarker testing. Technologies such as NGS and PCR-based diagnostics are gaining significant traction across the region.
Analysis of Key Players
• Abbott Laboratories
• Agilent Technology
• Becton, Dickinson and Company
• Bio-Rad Laboratories
• BioMerieux SA (Astute Medical)
• Merck KGaA
• Qiagen NV
• Quanterix
• Quest Diagnostics
• Thermo Fisher Scientific Inc.
These companies focus on product innovation, strategic collaborations, and expanding diagnostic capabilities to strengthen their market positions. Each has been profiled in the biomarkers market report based on company overview, business strategies, financial performance, product portfolio, and business segments.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Remember me
Comments (0)